Prevalence of Allergic Diseases in Children with Inflammatory Bowel Disease

Overview

Journal Postepy Dermatol Alergol

Publisher Termedia

Specialty Allergy & Immunology

Date 2019 Jul 24

PMID 31333345

Citations 5

Authors

Zuzanna Wasielewska

Aleksandra Dolinska

Dominika Wilczynska

Anna Szaflarska-Poplawska

Aneta Krogulska

Affiliations

Soon will be listed here.

Abstract

Introduction: There are many similarities between inflammatory bowel disease (IBD) and allergic diseases, including similar epidemiological data, pathomechanism, clinical course and even treatment methods. So far, many studies of IBD comorbidity with other diseases, including allergy, but mainly in adults, have been conducted.

Aim: To analyse the prevalence of allergic diseases, i.e. food allergy (FA), cow's milk allergy (CMA), atopic dermatitis (AD), allergic rhinitis (AR) and asthma in children with IBD.

Material And Methods: The study included 105 IBD patients from the Department of Paediatrics, Allergology and Gastroenterology of in Bydgoszcz and 100 children without IBD from the Outpatient Clinics. The authors applied the validated questionnaire as a study method.

Results: At least one allergic disease was found in 26 (43%) IBD children. The allergological diagnosis was made in IBD children more frequently than in the control group ( = 0.04). The difference was more noticeable with regards to skin prick tests ( = 0.02). FA was the most common disease; it was noted in 19 (32%) IBD children; followed by: AD - in 13 (22%), CMA - in 12 (20%), AR - in 10 (17%) and asthma - in 6 (10%) children. The prevalence of allergic diseases in the control and study groups was comparable ( > 0.05). There was no correlation between age of IBD children and allergy ( > 0.05). Asthma was significantly more common in children undergoing biological treatment ( = 0.01).

Conclusions: Children with IBD should be constantly monitored by medical professionals, not only due to the underlying disease but also due to a possible concomitant allergic disease.

Citing Articles

Atopy and allergic diseases among college students at a Saudi Public University.

Bin Abdulrahman K, Alqasem A, Alsayyari A, Bintalib S, Khatlah A, Alshehri M J Family Med Prim Care. 2024; 13(5):1944-1949.

PMID: 38948585 PMC: 11213384. DOI: 10.4103/jfmpc.jfmpc_1748_23.

No Association Between Allergic Diseases and Constipation in Japanese Ulcerative Colitis Patients: A Cross-Sectional Study.

Yagi S, Furukawa S, Suzuki S, Ohashi K, Tomida H, Yamamoto Y Cureus. 2024; 16(3):e55912.

PMID: 38601382 PMC: 11003880. DOI: 10.7759/cureus.55912.

Akkermansia muciniphila exacerbates food allergy in fibre-deprived mice.

Parrish A, Boudaud M, Grant E, Willieme S, Neumann M, Wolter M Nat Microbiol. 2023; 8(10):1863-1879.

PMID: 37696941 PMC: 10522492. DOI: 10.1038/s41564-023-01464-1.

IgE-Dependent Food Sensitisation and Its Role in Clinical and Laboratory Presentation of Paediatric Inflammatory Bowel Disease.

Buczynska A, Grzybowska-Chlebowczyk U, Pawlicki K Nutrients. 2023; 15(8).

PMID: 37111022 PMC: 10145321. DOI: 10.3390/nu15081804.

Establishment of Food Allergy Model in Dextran Sulfate Sodium Induced Colitis Mice.

Chen B, Wu Y, Wu H, Meng X, Chen H Foods. 2023; 12(5).

PMID: 36900524 PMC: 10001293. DOI: 10.3390/foods12051007.

References

Bischoff S, Lorentz A, Schwengberg S, Weier G, Raab R, Manns M . Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue. Gut. 1999; 44(5):643-52. PMC: 1727516. DOI: 10.1136/gut.44.5.643. View

Lilja I, Franzen L, Sjodahl R . Tumor necrosis factor-alpha in ileal mast cells in patients with Crohn's disease. Digestion. 2000; 61(1):68-76. DOI: 10.1159/000007737. View

Myrelid P, Dufmats M, Lilja I, Grinn C, Lannerstad O, Sjodahl R . Atopic manifestations are more common in patients with Crohn disease than in the general population. Scand J Gastroenterol. 2004; 39(8):731-6. DOI: 10.1080/00365520410005955. View

Kanazawa H, Yoshikawa J . A case-control study of bronchial asthma associated with ulcerative colitis: role of airway microvascular permeability. Clin Exp Allergy. 2005; 35(11):1432-6. DOI: 10.1111/j.1365-2222.2005.02358.x. View

Rothfuss K, Stange E, Herrlinger K . Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol. 2006; 12(30):4819-31. PMC: 4087615. DOI: 10.3748/wjg.v12.i30.4819. View

Black H, Mendoza M, Murin S . Thoracic manifestations of inflammatory bowel disease. Chest. 2007; 131(2):524-32. DOI: 10.1378/chest.06-1074. View

Karolewska-Bochenek K, Lazowska-Przeorek I, Albrecht P, Grzybowska K, Ryzko J, Szamotulska K . Epidemiology of inflammatory bowel disease among children in Poland. A prospective, population-based, 2-year study, 2002-2004. Digestion. 2009; 79(2):121-9. DOI: 10.1159/000209382. View

Gearry R, Richardson A, Frampton C, Dodgshun A, Barclay M . Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol. 2010; 25(2):325-33. DOI: 10.1111/j.1440-1746.2009.06140.x. View

Tzanakis N, Tsiligianni I, Siafakas N . Pulmonary involvement and allergic disorders in inflammatory bowel disease. World J Gastroenterol. 2010; 16(3):299-305. PMC: 2807949. DOI: 10.3748/wjg.v16.i3.299. View

10.

Keil T, Bockelbrink A, Reich A, Hoffmann U, Kamin W, Forster J . The natural history of allergic rhinitis in childhood. Pediatr Allergy Immunol. 2010; 21(6):962-9. DOI: 10.1111/j.1399-3038.2010.01046.x. View

11.

Benchimol E, Fortinsky K, Gozdyra P, van den Heuvel M, Van Limbergen J, Griffiths A . Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2010; 17(1):423-39. DOI: 10.1002/ibd.21349. View

12.

Hemdan N, Birkenmeier G, Wichmann G, El-Saad A, Krieger T, Conrad K . Interleukin-17-producing T helper cells in autoimmunity. Autoimmun Rev. 2010; 9(11):785-92. DOI: 10.1016/j.autrev.2010.07.003. View

13.

Levine A, Griffiths A, Markowitz J, Wilson D, Turner D, Russell R . Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011; 17(6):1314-21. DOI: 10.1002/ibd.21493. View

14.

Henderson P, Hansen R, Cameron F, Gerasimidis K, Rogers P, Bisset W . Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflamm Bowel Dis. 2011; 18(6):999-1005. DOI: 10.1002/ibd.21797. View

15.

Kappelman M, Galanko J, Porter C, Sandler R . Association of paediatric inflammatory bowel disease with other immune-mediated diseases. Arch Dis Child. 2011; 96(11):1042-6. DOI: 10.1136/archdischild-2011-300633. View

16.

Martin-de-Carpi J, Rodriguez A, Ramos E, Jimenez S, Martinez-Gomez M, Medina E . Increasing incidence of pediatric inflammatory bowel disease in Spain (1996-2009): the SPIRIT Registry. Inflamm Bowel Dis. 2012; 19(1):73-80. DOI: 10.1002/ibd.22980. View

17.

Turner D, Levine A, Escher J, Griffiths A, Russell R, Dignass A . Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr. 2012; 55(3):340-61. DOI: 10.1097/MPG.0b013e3182662233. View

18.

Virta L, Ashorn M, Kolho K . Cow's milk allergy, asthma, and pediatric IBD. J Pediatr Gastroenterol Nutr. 2013; 56(6):649-51. DOI: 10.1097/MPG.0b013e318285e9d8. View

19.

Glassman M, Newman L, Berezin S, GRYBOSKI J . Cow's milk protein sensitivity during infancy in patients with inflammatory bowel disease. Am J Gastroenterol. 1990; 85(7):838-40. View

20.

Chuang C, Lin S, Chen C, Sheu B, Kao A, Wang J . Increasing incidence and lifetime risk of inflammatory bowel disease in Taiwan: a nationwide study in a low-endemic area 1998-2010. Inflamm Bowel Dis. 2013; 19(13):2815-9. DOI: 10.1097/01.MIB.0000435436.99612.27. View